Showing results (591-600 of 626) with videos related to
Sort By:
Pageof 63
Nature Genetics|March 22, 2006
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisColin N A Palmer, Alan D Irvine, Ana Terron-Kwiatkowski, et al.Human Molecular Genetics|August 14, 2003
An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndromeW H Irwin McLean, Alan D Irvine, Kevin J Hamill, et al.Nature Genetics|April 10, 2007
Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczemaAileen Sandilands, Ana Terron-Kwiatkowski, Peter R Hull, et al.Clinical and Experimental Dermatology|April 1, 2025
Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT)Mandy Wan, Ashley P Jones, Daniel Maskrey, et al.The Journal of Investigative Dermatology|September 5, 2025
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, David Prieto-Merino, Bolaji Coker, et al.The Journal of Allergy and Clinical Immunology|July 24, 2018
Clinical and genetic differences between pustular psoriasis subtypesSophie Twelves, Alshimaa Mostafa, Nick Dand, et al.Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.The British Journal of Dermatology|September 9, 2024
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema CouncilCarter Haag, Andrew Alexis, Valeria Aoki, et al.The British Journal of Dermatology|August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaA L Bosma, P I Spuls, I Garcia-Doval, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.Pageof 63